Nano-aggregates: Emerging delivery tools for tumor therapy

Critical Reviews in Therapeutic Drug Carrier Systems

Volumn 30, Issue 6, 2013, Pages 535-563

  Sharma, Vinod Kumar ^a   Jain, Ankit ^a   Soni, Vandana ^a  

^a DR H S GOUR UNIVERSITY   (India)

Author keywords

Chemotherapy; Doxorubicin; Nano aggregates; Self assembly; Tumor

Indexed keywords

CAMPTOTHECIN; CISPLATIN; DOCETAXEL; DOXORUBICIN; DTXL TNP; FIRTECAN; MACROGOL; NANOCARRIER; NC 6004; NK 105; NK 911; PACLITAXEL; SP 1049 C; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER THERAPY; CELL VIABILITY; CRITICAL MICELLE CONCENTRATION; CROSS LINKING; CYTOTOXICITY; DRUG ACCUMULATION; DRUG DISTRIBUTION; DRUG TARGETING; FREEZE DRYING; HUMAN; INTERNALIZATION; LOADING TEST; NANOENCAPSULATION; NEOPLASM; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PHASE 4 CLINICAL TRIAL (TOPIC); SCANNING ELECTRON MICROSCOPY; SUSTAINED DRUG RELEASE; TRANSMISSION ELECTRON MICROSCOPY; TUMOR VASCULARIZATION;

ANIMALS; ANTINEOPLASTIC AGENTS; DRUG CARRIERS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; HUMANS; MICELLES; NANOSTRUCTURES; NANOTECHNOLOGY; PATENTS AS TOPIC; TISSUE DISTRIBUTION;

EID: 84885083450     PISSN: 07434863     EISSN: 2162660X     Source Type: Journal    
DOI: 10.1615/CritRevTherDrugCarrierSyst.2013007706     Document Type: Article

References (125)

1. Moscow JA, Cowan KH. Biology of cancer. In: Goldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia: Saunders Elsevier; 2007. pp 1345-8.
2. Jain RK. Barriers to drug delivery in solid tumors. Sci Am. 1994;271:58-65.
3. Jain RK. Delivery of molecules, particles and cells to solid tumors. Ann Biomed Eng. 1996;24:457-73.
4. World Health Organization: fact sheet cancer [cited 2013 Feb 14]. http://www.who.int/ mediacentre/ factsheets/fs297/en/index.html.
5. Ross JS, Schenkein DP, Pietrusko R. Targeted therapies for cancer. Am J Clin Pathol. 2004;122:598-609.
6. Maeda H. The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv Enzyme Regul. 2001;41:189-207.
7. Allen TM. Ligand-targeted therapeutics in anticancer therapy. Nat Rev Cancer. 2002;2:750-63.
8. Larsen AK, Escargueil AE, Skladanowski A. Resistance mechanisms associated with altered intracellular distribution of anticancer agents. Pharmacol Ther. 2000;85:217-29.
9. Matsumura Y. Poly (amino acid) micelle nanocarriers in preclinical and clinical studies. Adv Drug Deliv Rev. 2008;60:899-914.
10. Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release. 2000;65:271-84.
11. Chang G, Li C, Lu W, Ding J. N-boc-histidine-capped PLGA-PEG-PLGA as a smart polymer for drug delivery sensitive to tumor extracellular pH. Macromol Biosci. 2010;10:1248-56.
12. Duncan R. Polymer conjugates as anticancer nanomedicines. Nat Rev Cancer. 2006;6:688-701.
13. Li C, Wallace S. Polymer-drug conjugates: recent development in clinical oncology. Adv Drug Deliv Rev. 2008;60:886-98.
14. Vicent MJ, Ringsdorf H, Duncan R. Polymer therapeutics: clinical applications and challenges for development preface. Adv Drug Deliv Rev. 2009;61:1117-20.
15. Strebhardt K, Ullrich A. Paul Ehrlich's magic bullet concept: 100 years of progress. Nat Rev Cancer. 2008;8:473-80.
16. Ringsdorf H. Structure and properties of pharmacologically active polymers. J Polym Sci Polym Symp. 1975;51:135-53.
17. Jin Y, Song L, Su Y, Zhu LJ, Pang Y, Qiu F, Tong GS, Yan DY, Zhu BS, Zhu XY. Oxime link: a robust tool for the design of pH-sensitive polymeric drug carriers. Biomacromolecules. 2011;12:3460-8.
18. Torchilin VP. Micellar nanocarriers: pharmaceutical perspectives. Pharm Res. 2007;24:1-16.
19. Yokoyama M. Polymeric micelles as a new drug carrier system and their required considerations for clinical trials. Expert Opin Drug Deliv. 2010;7:145-58.
20. Blanco E, Kessinger CW, Sumer BD, Gao J. Multifunctional micellar nanomedicine for cancer therapy. Exp Biol Med. 2009;234:123-31.
21. Yokoyama M, Okano T, Sakurai Y, Suwa S, Kataoka K. Introduction of cisplatin into polymeric micelles. J Control Release. 1996;39:351-6.
22. Torchilin VP. Structure and design of polymeric surfactant based drug delivery systems. J Control Release. 2001;73:137-72.
23. Gref R, Minamitake Y, Percocchia MT, Trubetskoy V, Torchillin VP, Langer R. Biodegradable longcirculating polymeric nanospheres. Science. 1994;263:1600-3.
24. Nakajima TE, Yasunaga M, Kano Y, Koizumi F, Kato K, Hamaguchi T, Yamada Y, Shirao K, Shimada Y, Matsumura Y. Synergistic antitumor activity of the novel SN-38-incorporating polymeric micelles, NK012, combined with 5-fluorouracil in a mouse model of colorectal cancer, as compared with that of irinotecan plus 5-fluorouracil. Int J Cancer. 2008;122:2148-53.
25. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 2001;46:3-26.
26. Li DC, Zhong XK, Zeng ZP, Jiang JG, Li L, Zhao MM, Yang XQ, Chen J, Zhang BS, Zhao QZ, Xie MY, Xiong H, Deng ZY, Zhang XM, Xu SY, Gao YX. Application of targeted drug delivery system in Chinese medicine. J Control Release. 2009;138:103-12.
27. Gao Z, Eisenberg A. A model of micellization for block copolymers in solutions. Macromolecules. 1993;26:7353-60.
28. Wang YC, Li Y, Sun TM, Xiong MH, Wu J, Wang J. Core-shell-corona micelle stabilized by reversible cross-linkage for intracellular drug delivery. Macromol Rapid Commun. 2010;31:1201-6.
29. Kataoka K, Kwon GS, Yokoyama M, Okano T, Sakurai Y. Block copolymer micelles as vehicles for drug delivery. J Control Release. 1993;24:119-32.
30. Kataoka K, Harada A, Nagasaki Y. Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv Drug Deliv Rev. 2001;47:113-31.
31. Zhu J, Zhou Z, Yang C, Kong D, Wan Y, Wang Z. Folate-conjugated amphiphilic star-shaped block copolymers as targeted nanocarriers. J Biomed Mater Res. 2011;97:498-508.
32. Kwon GS, Yokoyama M, Okano T, Sakurai Y, Kataoka K. Biodistribution of micelle-forming polymer drug conjugates. Pharm Res. 1993;10:970-4.
33. Tao YH, Liu R, Chen MQ, Yang C, Liu XY. Cross-linked micelles of graft like block copolymer bearing biodegradable epsilon-caprolactone branches: a novel delivery carrier for paclitaxel. J Mater Chem. 2012;22:373-80.
34. Yokoyama M, Fukushima S, Uehara R, Okamoto K, Kataoka K, Sakurai Y, Okano T. Characterization of physical entrapment and chemical conjugate of adriamycin in polymeric micelles and their design for in vivo delivery to a solid tumor. J Control Release. 1998;50:79-92.
35. Nakanishi T, Fukushima S, Okamoto K, Suzuki M, Matsumura Y, Yokoyama M, Okano T, Sakurai Y, Kataoka K. Development of the polymer micelle carrier system for doxorubicin. J Control Release. 2001;74:295-302.
36. Li J, Huo MR, Wang J, Zhou JP, Mohammada JM, Zhang YL. Redox-sensitive micelles self-assembled from amphiphilic hyaluronic acid-deoxycholic acid conjugates for targeted intracellular delivery of paclitaxel. Biomaterials. 2012;33:2310-20.
37. Kwon GS, Okano T. Soluble self-assembled block copolymers for drug delivery. Pharm Res. 1999;16:597-600.
38. Yoo HS, Park TG. Biodegradable polymeric micelles composed of doxorubicin conjugated PLGA-PEG block copolymer. J Control Release. 2001;70:63-70.
39. Maeda H. Macromolecular therapeutics in cancer treatment: the EPR effect and beyond. J Control Release. 2012;164:138-44.
40. Lee SC, Kim C, Kwon IC, Chung H, Jeong SY. Polymeric micelles of poly (2-ethyl-2-oxazoline)-block-poly (q-caprolactone) copolymer as a carrier for paclitaxel. J Control Release. 2003;89:437-46.
41. Chu BCF, Kramer FR, Orgel LE. Synthesis of an amplifiable reporter RNA for bioassays. Nucleic Acid Res. 1986;14:5591-603.
42. Ghosh SS, Kao PM, MeCue W, Chappell H L. Use of maleimide-thiol coupling chemistry for efficient syntheses of oligonucleotide-enzyme conjugate hybridization probes. Bioconjugate Chem. 1990;1:171-6.
43. Carlsson J, Drevin H, Axen R. Protein thiolation and reversible protein-protein conjugation; N-Succinimidyl 3-(2-pyridyldithio)propionate, a new heterobifunctional reagent. Biochem J. 1978;173:723-37.
44. Kabanov AV, Vinogradov SV, Suzdaltseva YG, Alakhov V. Water-soluble block polycations as carriers for oligonucleotide delivery. Bioconjug Chem. 1995;6:639-43.
45. Kakizawa Y, Kataoka K. Block copolymer micelles for delivery of gene and related compounds. Adv Drug Deliv Rev. 2002;54:203-22.
46. Kataoka K, Harada A, Nagasaki Y. Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv Drug Deliv Rev. 2001;47:113-31.
47. Kataoka K, Kwon GS, Yokoyama M, Okano T, Sakurai Y. Block copolymer micelles as vehicles for drug delivery. J Control Release. 1993;24:119-32.
48. Kwon GS. Diblock copolymer nanoparticles for drug delivery. Crit Rev Ther Drug Carrier Syst. 1998;15:481-512.
49. Kwon GS. Block copolymer micelles as drug delivery systems. Adv Drug Deliv Rev. 2002;54:167.
50. Kwon GS. Polymeric micelles for delivery of poorly water-soluble compounds. Crit Rev Ther Drug Carrier Syst. 2003;20:357-403.
51. Kwon GS, Okano T. Soluble self-assembled block copolymers for drug delivery. Pharm Res. 1999;16:597-600.
52. Lavasanifar A, Samuel J, Kwon GS. Poly (ethylene oxide)-block-poly (L-amino acid) micelles for drug delivery. Adv Drug Deliv Rev. 2002;54:169-90.
53. Torchilin VP. PEG-based micelles as carriers of contrast agents for different imaging modalities. Adv Drug Deliv Rev. 2002;54:235-52.
54. Torchilin VP. Targeted polymeric micelles for delivery of poorly soluble drugs. Cell Mol Life Sci. 2004;61:2549-59.
55. Letchford K, Burt HM. Copolymer micelles and nanospheres with different in vitro stability demonstrate similar Paclitaxel pharmacokinetics. Mol Pharm. 2012;9:248-60.
56. Torchilin VP. Structure and design of polymeric surfactant-based drug delivery systems. J Control Release. 2001;73:137-72.
57. Jones M, Leroux J. Polymeric micelles: a new generation of colloidal drug carriers. Eur J Pharm Biopharm. 1999;48:101-11.
58. Harada A, Kataoka K. Formation of polyion complex micelles in an aqueous milieu from a pair of oppositely-charged block copolymers with poly (ethylene glycol) segments. Macromolecules. 1995;28:5294-9.
59. Elliott RL, Elliott MC, Wang F, Head JF. Breast carcinoma and the role of iron metabolism: a cytochemical, tissue culture and ultrastructural study. Ann N Y Acad Sci. 1993;698:159-66.
60. Kim JH, Emoto K, Iijima M, Nagasaki Y, Aoyagi T, Okano TY. Core-stabilized polymeric micelle as potential drug carrier: increased solubilization of taxol. Polym Adv Technol. 1999;10:647-54.
61. Zhiang J, Wu M, Yang J, Wu Q, Jin Z. Anionic poly (lactic acid)-polyurethane micelles as potential biodegradable drug delivery carriers. Colloids Surfaces A. 2009;337:200-4.
62. Patil YB, Toti US, Khdair A, Linan M, Panyam J. Single-step surface functionalization of polymeric nanoparticles for targeted drug delivery. Biomaterials. 2009;30:859-66.
63. Chung JE, Yokoyama M, Okano T, Yamato M, Aoyagi T, Sakurai Y. Thermoresponsive drug delivery from polymeric micelles constructed using block copolymer of poly(N-isopropylacrylamide) and poly(butyl methacrylate). J Control Release. 1999;62:115-27.
64. Li Y, Kwon GS. Methotrexate esters of poly (ethylene oxide)-block-poly(2-hydroxyethyl-L-aspartamide): I. Effects of the level of methotrexate conjugation on the stability of micelles and on drug release. Pharm Res. 2000;17:607-11.
65. Lavasanifar A, Samuel J, Kwon GS. Micelles self-assembled from poly (ethylene oxide)-blockpoly(N-hexyl stearate L-aspartamide) by a solvent evaporation method: effect on the solubilization and haemolytic activity of amphotericin B. J Control Release. 2001;77:155-60.
66. Wihelm M, Zhao CL, Wang Y. Poly (styrene ethylene oxide) block copolymer micelle formation in water: A fluorescence probe study. Macromolecules. 1991;24:1033-40.
67. Astafieva I, Zhong XF, Eisenberg A. Critical micellization phenomena in block polyelectrolyte solutions. Macromolecules. 1993;26:7339-52.
68. Yunhai L, Xiaohong C, Mingbiao L, Zhanggao L, Wenyuan X. Self assembled micellar nanoparticles of a novel star copolymer for thermo and pH dual-responsive drug release. J Colloid Interface Sci. 2009;329:244-52.
69. Ashok B, Arleth L, Hjelm RP, Rubinstein I. In vitro characterization of pegylated phospholipid micelle for improved drug solubilization: effects of PEG chain length and PC incorporation. J Pharm Sci. 2004;93:2476-87.
70. Kwon G, Naito M, Yokoyama M, Okano T, Sakurai Y, Kataoka K. Micelle based on AB block copolymers of poly (ethylene oxide) and poly (beta-benzyl L-aspartate). Langmuir. 1993;9:945-9.
71. Wilhelm M, Zhao CL, Wang YC, Xu RL, Winnik MA, Mura JL. Poly (styrene-ethylene oxide) block copolymer micelle formation in water: a fluorescence probe study. Macromolecules. 1991;24:1033-40.
72. Kabanov AV, Batrakova EV, Alakhov VY. Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery. J Control Release. 2002;82:189-212.
73. Jianzheng Z, Wei J. Xiuwen Z, Yundong W. Preparation and characterization of polymeric micelle from poly(D, L-lactide) and methoxypolyethylene glycol block copolymers as potential drug carriers. Tsinghua Sci Technol. 2007;12:493-6.
74. Yoo HS, Park TG. Biodegradable polymeric micelle composed of doxorubicin conjugated PLGA-PEG block copolymer. J Control Release. 2001;70:63-70.
75. Yoo HS, Lee EA, Park TG. Doxorubicin-conjugated biodegradable polymeric micelle having acidcleavable linkages. J Control Release. 2002;82:17-27.
76. Bussche EV, Deene YD, Dubruel P, Vergote K, Schacht E, Wagter CD. The use of static light scattering for the structure analysis of radiosensitive polymer gels: a literature survey. J Phys Conf Ser. 2004;3:180-3.
77. Son YJ, Jang JS, Cho YW, Chung H, Park RW, Kwon IC, Kim I, Park JY, Seo SB, Park CR, Jeong SY. Biodistribution and anti-tumor efficacy of doxorubicin loaded glycol-chitosan micelle by EPR effect. J Control Release. 2009;91:135-45.
78. Prasad V, Semwogerere D, Eric RW. Confocal microscopy of colloids. J Phys Condense Matter. 2007;19:113-38.
79. Lee H, Soo PL, Liu J, Butler M, Allen C. Polymeric micelle for formulation of anticancer drugs. In: Amiji MM, editor. Nanotechnology for cancer therapy. Boca Raton (FL): CRC Press; 2007: 317-55.
80. Jianzheng Z, Wei J. Xiuwen Z, Yundong W. preparation and characterization of polymeric nanoaggregates from poly(d, l-lactide) and methoxypolyethylene glycol block copolymers as potential drug carriers. Tsinghua Sci Technol. 2007;12:493-6.
81. Adams ML, Lavasanifar A, Kwon GS. Amphiphilic block copolymers for drug delivery. J Pharm Sci. 2003;92:1343-55.
82. Allen C, Eisenberg A, Maysinger D. Copolymer drug carriers: conjugates, micelles and microspheres. STP Pharm Sci. 1999;9:139-51.
83. Duncan R. The dawning era of polymer therapeutics. Nat Rev Drug Discov. 2003;2:347-60.
84. Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumor tropic accumulation of proteins and the antitumor agent. Cancer Res. 1986;46:6387-92.
85. Maeda H. The enhanced permeability and retention (EPR) effect in tumor vasculature, the key role of tumor selective macromolecular drug targeting. Adv Enzyme Regul. 2001;41:189-207.
86. Maeda H, Sawa T, Konno T. Mechanism of tumor targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug. J Control Release. 2001;74:47-61.
87. Yuan F, Delian M, Fukumura D, Leunig M, Berk DA, Torchilin VP. Vascular permeability in a human tumor xenograft: molecular size dependence and cut off size. Cancer Res. 1995;55:3752-6.
88. Haag R, Kratz F. Polymer therapeutics: concepts and applications. Angew Chem Int Ed Eng. 2006;45:1198-215.
89. Seymour LW, Miyamoto Y, Maeda H. Influence of molecular weight on passive tumor accumulation of a soluble macromolecular drug carrier. Eur J Cancer. 1995;31:766-70.
90. Minko T, Dharap SS, Pakunlu RI, Wang Y. Molecular targeting of drug delivery systems to cancer. Curr Drug Targets. 2004;5: 389-406.
91. Wang L, Zeng R, Li C, Qiao R. Self-assembled polypeptide-block-poly (vinylpyrrolidone) as prospective drug-delivery systems. Colloids Surfaces B. 2009;74:284-92.
92. Dharap SS, Qiu B, Williams GC, Sinko P, Stein S, Minko T. Molecular targeting of drug delivery systems to ovarian cancer by BH3 and LHRH peptides. J Control Release. 2003;91:61-73.
93. Zhao H, Yung LYL. Selectivity of folate conjugated polymer micelles against different tumor cells. Int J Pharm. 2008;349:256-68.
94. Yoo HS. Park TG. Folate receptor targeted delivery of doxorubicin nano-aggregates stabilized by doxorubicin-PEG-folate conjugate. J Control Rel. 2004;100:247-56.
95. Wu Y, Chen W, Meng F, Wang Z, Cheng R, Deng C, Liu H, Zhong Z. Core-crosslinked pH-sensitive degradable micelles: A promising approach to resolve the extracellular stability versus intracellular drug release dilemma. J Control Release. 2012;164:338-45.
96. Barz M, Armiñán A, Canal F, Wolf F, Koynov K, Frey H, Zentel R, Vicent MJ. P(HPMA)-block-P(LA) copolymers in paclitaxel formulations: Polylactide stereochemistry controls micellization, cellular uptake kinetics, intracellular localization and drug efficiency. J Control Release. 2012;163:63-74.
97. Yoo HS, Lee EA, Park TG. Doxorubicin-conjugated biodegradable polymeric micelles having acidcleavable linkages. J Control Release. 2002;82:17-27.
98. Yoo HS, Park TW. Folate receptor targeted biodegradable polymeric doxorubicin micelles. J Control Release. 2004;96:273-83.
99. Le Garrec D, Gori S, Luo L. Poly (N-vinylpyrrolidone)-block-poly(D, L-lactide) as a new polymeric solubilizer for hydrophobic anticancer drugs: in vitro and in vivo evaluation. J Control Release. 2004;99:83-101.
100. Aliabadi HM, Brocks DR, Lavasanifar A. Polymeric micelles for the solubilization and delivery of cyclosporine A: pharmacokinetics and biodistribution. Biomaterials. 2005;26:7251-9.
101. Kim SC, Kim DW, Shim YH. In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy. J Control Release. 2001;72:191-202.
102. Kawano K, Watanabe M, Yamamoto T. Enhanced antitumor effect of camptothecin loaded in longcirculating polymeric micelles. J Control Release. 2006;112:329-32.
103. Yokoyama M, Okano T, Sakurai Y. Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood. Cancer Res. 1991;51:3229-36.
104. Tian HY, Deng C, Lin H. Biodegradable cationic PEG-PEI-PBLG hyper branched block copolymer: synthesis and micelle characterization. Biomaterials. 2005;26:4209-17.
105. Sparreboom A, Scripture CD, Trieu V. Comparative preclinical and clinical pharmacokinetics of a cremophor-free, nanoparticle albumin-bound paclitaxel (ABI-007) and paclitaxel formulated in cremophor (taxol). Clin Cancer Res. 2005;11:4136-43.
106. Negishi T, Koizumi F, Uchino H. NK105, a paclitaxel-incorporating micellar nanoparticle, is a more potent radio sensitising agent compared to free paclitaxel. Br J Cancer. 2006;95:601-6.
107. Kim DW, Kim SY, Kim HK. Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer. Ann Oncol. 2007;18:2009-14.
108. Matsumura Y, Hamaguchi T, Ura T. Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin. Br J Cancer. 2004;91:1775-81.
109. Danson S, Ferry D, Alakhov V. Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer. Br J Cancer. 2004;90:2085-91.
110. Torchilin VP, Inventor; Micelles delivery system loaded with a pharmaceutical agent. US Patent US 20060216342A1. 2006 Sep. 28.
111. Lavasanifar A, Kwon GS, Inventor; Polymer based nano-carriers for the solubilization and delivery of hydrophobic drugs. World Intellectual Property Organization WO2005118672A1. 2005 Dec.15.
112. Chol YK, Kim JS, Inventor; Samyang Corporation, Seoul (KR); Assignee. Biodegradable mixed polymeric micelles for gene delivery. US Patent US006210717B1. 2001 Apr 3.
113. Kim SC, Chang EO, Song IS, Pal CM, Inventor; Samyang Corporation, Seoul (KR), Assignee. Biodegradable polymeric micelle type drug composition and method for the preparation thereof. US Patent US006322805 B1. 2001 Nov 27.
114. Chol YK, Kim JS, Inventor; Samyang Corporation, Taejon (KR), Assignee. Biodegradable mixed polymeric micelles for drug delivery. US Patent US 006410057B1. 2002 June 25.
115. Ranger M, Leroux JC, Inventor; Labopharm, Inc., Quebec (Canada), Assignee. Unimolecular polymeric micelles with an ionizable inner core. US Patent US006780428. 2004 Aug 24.
116. Seo MH, Lee SW, Inventor; Samyang Corporation, Assignee. Preparation method of polymeric micelles composition containing a poorly water-soluble drug. US Patent US20110251269. 2011 Oct 13.
117. Bae YH, Lee ES, Na K, Inventor; You Han Bae, Lee Eun Seong, Kun Na, Assignee. pH-sensitive polymeric micelles for drug delivery. US Patent US7229973 B2. 2007 Jun 12.
118. Yokoyama M, Sakurai Y, Okano T, Kataoka K, Inventor; Research Development Corporation of Japan (JP) Assignee. Physical trapping type polymeric micelle drug preparation. US Patent US5510103. 1996 Apr 23.
119. Leroux JC, Ranger M, Inventor; Jean-Christophe Leroux, Maxime Ranger, Assignee. unimolecular polymeric micelles with an ionizable inner core. US Patent US20020187199 A1. 2002 Dec 12.
120. De P, Inventor; Phaserx, Inc., University Of Washington, Assignee. Heterogeneous polymeric micelles for intracellular delivery. US Patent US20120021514. 2011 Jun 15.
121. Alani AW, Bae Y, Kwon GS, Inventor; Adam Wg Alani, Younsoo Bae, Glen S. Kwon, Wisconsin Alumni Research Foundation, Assignee. Polymeric micelles for combination drug delivery. US Patent US20080248097. 2008 Sep 4.
122. Mirosevich J, Cardoen G, Sill KN, Skaff H, Inventor; Intezyne Technologies, Inc. Assignee. Polymeric micelles for polynucleotide encapsulation. US Patent US20100278927. 2012 Oct. 16.
123. Lu Y, Park K. Polymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugs. Int J Pharm. 2013;453:198-214.
124. Matsumura Y. Polymeric micellar delivery systems in oncology. Jpn J Clin Oncol. 2008;38:793-802.
125. Oerlemans C, Bult W, Bos M, Storm G, Frank J, Nijsen W, Hennink E. Polymeric micelles in anticancer therapy: targeting, imaging and triggered release. Pharm Res. 2010;27:2569-89.